108 related articles for article (PubMed ID: 31446540)
1. Clinical spectrums and outcomes of necrotizing autoimmune myopathy versus other idiopathic inflammatory myopathies: a multicenter case-control study.
Yongchairat K; Tanboon J; Waisayarat J; Narongroeknawin P; Chevaisrakul P; Dejthevaporn C; Katchamart W
Clin Rheumatol; 2019 Dec; 38(12):3459-3469. PubMed ID: 31446540
[TBL] [Abstract][Full Text] [Related]
2. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.
Yang H; Peng Q; Yin L; Li S; Shi J; Zhang Y; Lu X; Shu X; Zhang S; Wang G
Arthritis Res Ther; 2017 Nov; 19(1):259. PubMed ID: 29178913
[TBL] [Abstract][Full Text] [Related]
3. Necrotizing Autoimmune Myopathy: Clinicopathologic Study from a Single Tertiary Care Centre.
Ayesha SM; Meena AK; Vangala N; Rajasekhar L; Kaul S; Borgahain R; Uppin MS
Ann Indian Acad Neurol; 2018; 21(1):62-67. PubMed ID: 29720800
[TBL] [Abstract][Full Text] [Related]
4. Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.
Oldroyd AGS; Callen JP; Chinoy H; Chung L; Fiorentino D; Gordon P; Machado PM; McHugh N; Selva-O'Callaghan A; Schmidt J; Tansley SL; Vleugels RA; Werth VP; ; Aggarwal R
Nat Rev Rheumatol; 2024 May; 20(5):315. PubMed ID: 38548933
[No Abstract] [Full Text] [Related]
5. Where are we moving in the classification of idiopathic inflammatory myopathies?
Tanboon J; Uruha A; Stenzel W; Nishino I
Curr Opin Neurol; 2020 Oct; 33(5):590-603. PubMed ID: 32852298
[TBL] [Abstract][Full Text] [Related]
6. Myositis-specific autoantibodies in adults with idiopathic inflammatory myopathy: correlations with diagnosis and disease activity.
Zhao L; Su K; Liu T; Sun D; Jiang Z
Clin Rheumatol; 2021 Mar; 40(3):1009-1016. PubMed ID: 32676923
[TBL] [Abstract][Full Text] [Related]
7. Anti-transcriptional intermediary factor 1-γ antibody as a biomarker in patients with dermatomyositis.
Shimizu K; Kobayashi T; Kano M; Hamaguchi Y; Takehara K; Matsushita T
J Dermatol; 2020 Jan; 47(1):64-68. PubMed ID: 31638280
[TBL] [Abstract][Full Text] [Related]
8. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
Allenbach Y; Benveniste O; Stenzel W; Boyer O
Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic modelling and therapeutic monitoring of immune-mediated necrotizing myopathy: role of electrical myotonia.
Triplett JD; Shelly S; Livne G; Milone M; Kassardjian CD; Liewluck T; Kelly C; Naddaf E; Laughlin RS; Lamb CJ; Rubin D; Dimberg EL; Dubey D; Mills JR; Mandrekar J; Klein CJ
Brain Commun; 2020; 2(2):fcaa191. PubMed ID: 33364599
[TBL] [Abstract][Full Text] [Related]
10. Juvenile idiopathic inflammatory myopathies with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in a Chinese cohort.
Hou Y; Shao K; Zhao B; Dai T; Wang Q; Zhao Y; Yan C; Yan Y; Ma X; Li W
CNS Neurosci Ther; 2021 May; 27(9):1041-7. PubMed ID: 33932258
[TBL] [Abstract][Full Text] [Related]
11. The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study.
Li S; Li W; Jiang W; He L; Peng Q; Wang G; Lu X
Front Pharmacol; 2021; 12():635654. PubMed ID: 33815117
[No Abstract] [Full Text] [Related]
12. [Clinicopathological Features of Myositis and Necrotizing Myopathy: How to Distinguish between Myositis and Muscular Dystrophy on Muscle Pathology].
Saito Y; Nishino I
Brain Nerve; 2021 Feb; 73(2):147-159. PubMed ID: 33561829
[TBL] [Abstract][Full Text] [Related]
13. Statin-associated anti-HMGCR immune-mediated necrotizing myopathy with dermatomyositis-like features: A case report.
Lim D; Landon-Cardinal O; Ellezam B; Belisle A; Genois A; Sirois J; Bourré-Tessier J
SAGE Open Med Case Rep; 2020; 8():2050313X20984120. PubMed ID: 33447390
[TBL] [Abstract][Full Text] [Related]
14. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histological features of immune-mediated necrotising myopathy: A multi-centre South Australian cohort study.
Day J; Otto S; Cash K; Limaye V
Neuromuscul Disord; 2020 Mar; 30(3):186-199. PubMed ID: 32229165
[TBL] [Abstract][Full Text] [Related]
16. Severe axial and pelvifemoral muscle damage in immune-mediated necrotizing myopathy evaluated by whole-body MRI.
Landon-Cardinal O; Koumako C; Hardouin G; Granger B; Reyngoudt H; Boisserie JM; Rigolet A; Hervier B; Champtiaux N; Guillaume-Jugnot P; Vautier M; Benveniste O; Carlier PG; Allenbach Y
Semin Arthritis Rheum; 2020 Dec; 50(6):1437-1440. PubMed ID: 32222382
[TBL] [Abstract][Full Text] [Related]
17. Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients.
Meyer A; Troyanov Y; Drouin J; Oligny-Longpré G; Landon-Cardinal O; Hoa S; Hervier B; Bourré-Tessier J; Mansour AM; Hussein S; Morin V; Rich E; Goulet JR; Chartrand S; Hudson M; Nehme J; Makhzoum JP; Zarka F; Villeneuve E; Raynauld JP; Landry M; O'Ferrall EK; Ferreira J; Ellezam B; Karamchandani J; Larue S; Massie R; Isabelle C; Deschênes I; Leclair V; Couture H; Targoff IN; Fritzler MJ; Senécal JL
Arthritis Res Ther; 2020 Jan; 22(1):5. PubMed ID: 31915059
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
[TBL] [Abstract][Full Text] [Related]
19. Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis.
Frasson E; Simonetto M; Bertolasi L; Caneve G; Vilotti C; Ruzza G; Perelli A; Piccinno MG; Monaco S
Clin Case Rep; 2021 May; 9(5):e03925. PubMed ID: 34026125
[TBL] [Abstract][Full Text] [Related]
20. Immune-Mediated Necrotizing Myopathy Initially Presenting as Erythema Nodosum.
Ying S; Li S; Tang S; Sun Q; Fang D; Li Y; Zhu D; Fang H; Qiao J
J Inflamm Res; 2020; 13():471-476. PubMed ID: 32922062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
